|
MRPS35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.124190E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.035700E-03 |
| Normal-vs-Stage2 |
8.744200E-02 |
| Normal-vs-Stage3 |
1.957950E-01 |
| Normal-vs-Stage4 |
8.447000E-01 |
| Stage1-vs-Stage2 |
9.211600E-01 |
| Stage1-vs-Stage3 |
6.164000E-01 |
| Stage1-vs-Stage4 |
3.421200E-01 |
| Stage2-vs-Stage3 |
7.472600E-01 |
| Stage2-vs-Stage4 |
3.408200E-01 |
| Stage3-vs-Stage4 |
5.318400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.767000E-04 |
| Normal-vs-AfricanAmerican |
1.803190E-01 |
| Normal-vs-Asian |
7.257600E-01 |
| Caucasian-vs-AfricanAmerican |
2.330400E-01 |
| Caucasian-vs-Asian |
6.959000E-01 |
| AfricanAmerican-vs-Asian |
9.840600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.177540E-03 |
| Normal-vs-Female |
3.608100E-02 |
| Male-vs-Female |
5.802000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.695680E-02 |
| Normal-vs-Extreme_Weight |
3.140400E-03 |
| Normal-vs-Obese |
3.968300E-02 |
| Normal-vs-Extreme_Obese |
3.227200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.870200E-01 |
| Normal_Weight-vs-Obese |
6.751400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.984800E-01 |
| Extreme_Weight-vs-Obese |
4.591000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.950000E-01 |
| Obese-vs-Extreme_Obese |
9.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.426200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.744800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.700600E-03 |
| Normal-vs-Age(81-100Yrs) |
1.433000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.473800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.573800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.038800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.320800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.147800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.621600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.803500E-04 |
| Normal-VS-Type2 PRCC |
3.229800E-01 |
| Normal-VS-KIRP CIMP |
1.703790E-01 |
| Normal-VS-Unclassified PRCC |
8.588300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.089250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.682400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.615400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.844200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.038200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.574400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.555200E-03 |
| Normal-vs-N1 |
7.637600E-01 |
| Normal-vs-N2 |
4.757000E-01 |
| N0-vs-N1 |
7.616200E-02 |
| N0-vs-N2 |
8.538000E-01 |
| N1-vs-N2 |
3.576600E-01 |
|
|
